Introduction to Fragile X mouse models

As noted in our very first post about clinical trials for Fragile X Syndrome: “The intention here is to take a slightly different perspective. First, it is interesting to note that in many articles describing the results of clinical trials, the repeated positive results of drug tests in “Fragile X” (FX) animal models are cited […]

An update on Fragile X Syndrome treatment research from the Stanford IDD-C Conference

The following video is shared from the FRAXA Research Foundation, whose research director, Dr. Michael Tranfaglia, M.D., gave a talk at the April 21, 2015 Stanford University Intellectual and Developmental Disability Center (IDD-C) research symposium. Dr. Tranfaglia provided both a review of the bases for recent clinical trials as well as various avenues for future […]